LABORATORY CORP OF AMERICA HOLDINGS
8-K, 2000-04-06
MEDICAL LABORATORIES
Previous: METACREATIONS CORP, 8-K, 2000-04-06
Next: CV THERAPEUTICS INC, DEF 14A, 2000-04-06






      UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                   WASHINGTON, D.C. 20549

                          FORM 8-K

                       CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
                        APRIL 4, 2000
                     ------------------
              (Date of earliest event reported)


         LABORATORY CORPORATION OF AMERICA HOLDINGS
         ------------------------------------------
   (Exact name of registrant as specified in its charter)


   DELAWARE                1-11353             13-3757370
 --------------          -----------         --------------
(State or other         (Commission         (IRS Employer
jurisdiction of         File Number)         Identification
incorporation)                                    Number)


   358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215
   -------------------------------------------------------
          (Address of principal executive offices)

                        336-229-1127
                        ------------
    (Registrant's telephone number, including area code)


<PAGE>

ITEM 5. OTHER EVENTS

  On  April  4,  2000,  Laboratory  Corporation  of  America
Holdings-Registered Trademark- (LabCorp-Registered Trademark-)
announced that it signed an extension  to its existing agreement
with Aetna U.S. Healthcare to provide laboratory  services  to
Aetna  U.S.  Healthcare members. Details of the long-term agreement
were not disclosed.


ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
        INFORMATION AND EXHIBITS

 (c)  Exhibit
      20  Press release of the Company dated
          April 4, 2000.


<PAGE>
                         SIGNATURES

Pursuant to the requirements of the Securities and Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.

          LABORATORY CORPORATION OF AMERICA HOLDINGS
          ------------------------------------------
                         (Registrant)

               By:/s/ BRADFORD T. SMITH
                  ------------------------------
                      Bradford T. Smith
                      Executive Vice President,
                      General Counsel, Secretary
                      and Compliance Officer



Date: April 6, 2000

<PAGE>



Laboratory Corporation of America-Registered Trademark- Holdings
358 South Main Street
Burlington, NC   27215
Telephone:  336-584-5171


Contact:  Pamela Sherry                       LabCorp Shareholder Direct
          336-436-4855                        800-LAB-0401
                                              www.labcorp.com


       LABORATORY CORPORATION OF AMERICA-REGISTERED TRADEMARK- ANNOUNCES
               NATIONAL AGREEMENT WITH AETNA U.S. HEALTHCARE

Burlington, NC, April 4, 2000 - Laboratory Corporation of
America-Registered Trademark- Holdings (LabCorp-Registered Trademark-)
(NYSE: LH) announced today that it has signed an extension to its
existing agreement with Aetna U.S. Healthcare to provide laboratory
services to Aetna U.S. Healthcare members.  Details of the long-term
agreement were not disclosed.

Effective April 1, LabCorp is one of the preferred national
providers offering clinical laboratory testing to members of
Aetna U.S. Healthcare's PPO, POS and indemnity plans
nationwide.  The agreement also provides the majority of Aetna
U.S. Healthcare's HMO members with access to the services
provided by LabCorp.

"We are delighted that Aetna U.S. Healthcare has selected
LabCorp and recognizes the value of providing physicians and
their patients with an alternative for laboratory services,"
said Thomas P. Mac Mahon, President and Chief Executive Officer
of LabCorp.  "LabCorp's national network is committed to
providing a full range of quality services to Aetna U.S.
Healthcare."

Laboratory  Corporation of America-Registered Trademark- Holdings
(LabCorp-Registered Trademark-) is a national  clinical  laboratory
with  annual  revenues  of  $1.7 billion  in  1999.   With  18,000
employees  and  over  100,000 clients nationwide, the company offers
more than 2,000 clinical tests  ranging  from  simple  blood analyses
to  sophisticated molecular  diagnostics.  LabCorp  leverages  its
expertise  in innovative  clinical testing technology with three
Centers  of Excellence. The Center for Molecular Biology and Pathology,
in Research   Triangle   Park  (RTP),  North  Carolina,   develops
applications  for  polymerase chain reaction (PCR)  technology.
Its  Center  for  Occupational Testing in RTP  is  the  world's
largest  substance abuse testing facility, and the  Center  for
Esoteric  Testing in Burlington, North Carolina,  performs  the
largest  volume of specialty testing in the network.  LabCorp's
clients  include  physicians,  state  and  federal  government,
managed  care organizations, hospitals, clinics, pharmaceutical
and Fortune 1000 companies, and other clinical laboratories.

<PAGE>
Aetna U.S. Healthcare is the nation's leading health and
related benefits organization, providing a full spectrum of
products ranging from health maintenance organizations (HMO) to
indemnity health insurance, group life and disability products,
and dental, vision, and pharmacy benefits to approximately 29
million Americans.  In addition, Aetna U.S. Healthcare provides
quality measurement and improvement programs and data analysis
for providers and purchasers of health care.  To learn more
about Aetna U.S. Healthcare, check out the website at
www.aetnaushc.com.

LabCorp noted that each of the above forward-looking statements
is  subject  to  change  based  on various  important  factors,
including  without  limitation,  competitive  actions  in   the
marketplace and adverse actions of governmental and other third-
party  payors.  Further information on potential  factors  that
could  affect each company's financial results is  included  in
the Form 10-K for each for the year ended December 31, 1999 and
subsequent SEC filings.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission